The Valley Desk

NCT07768371 · Interventional trial

A 52-week Study of Remibrutinib in IgE-mediated Food Allergy

Overall registry status Recruiting

Phase 3

Conditions Cow Milk Allergy, Egg Allergy, IgE-Mediated Food Allergy, Peanut Allergy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov